太龙药业: 太龙药业第十届董事会第一次会议决议公告

Core Points - The board of directors of Henan Tailong Pharmaceutical Co., Ltd. held its first meeting of the tenth session on August 15, 2025, with all nine directors present [1][2][3] - The meeting approved the election of Wang Rongtao as the chairman of the board, with a unanimous vote of 9 in favor [1] - Li Jingliang was elected as the vice chairman of the board, also with a unanimous vote of 9 in favor [2] - The board established various specialized committees, including the Strategy and Development Committee, Audit Committee, Nomination Committee, and Compensation and Assessment Committee, with all members elected unanimously [2] - Li Jingliang was appointed as the general manager of the company, with a unanimous vote of 9 in favor [3] - Su Fengshan was appointed as the executive vice general manager, and three others were appointed as vice general managers, all with unanimous approval [3] - Zhao Hailin was appointed as the financial officer, and Li Nianyun was appointed as the board secretary, both with unanimous votes [4] - Wu Ting was appointed as the securities affairs representative, also with unanimous approval [4]